Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 3Terminated 2Unknown 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Lymphoma 13Multiple Myeloma 8Lymphoma, Large B-Cell, Diffuse 8Lymphoma, Follicular 7Leukemia, Myeloid, Acute 7Leukemia 7Breast Neoplasms 7Neuroblastoma 6Neoplasms, Plasma Cell 6Lymphoma, Non-Hodgkin 6Lymphoma, Mantle-Cell 6Lymphoma, Large-Cell, Immunoblastic 6Precursor Cell Lymphoblastic Leukemia-Lymphoma 5Burkitt Lymphoma 5Leukemia, Lymphocytic, Chronic, B-Cell 4Hodgkin Disease 4Testicular Neoplasms 3Testicular Germ Cell Tumor 3Prostatic Neoplasms 3Myelodysplastic Syndromes 3Lymphoma, B-Cell, Marginal Zone 3Lung Neoplasms 3Leukemia, Myelomonocytic, Acute 3Leukemia, Monocytic, Acute 3Leukemia, Megakaryoblastic, Acute 3Leukemia, Erythroblastic, Acute 3Central Nervous System Neoplasms 3Waldenstrom Macroglobulinemia 2Seminoma 2Ovarian Neoplasms 2

Interventions

Sorafenib 9Radiofrequency Ablation 7Oxaliplatin 7Fluorouracil 6Doxorubicin 6Neoadjuvant Therapy 5toripalimab 4lenvatinib 4Injections 4Chemotherapy, Adjuvant 4Bevacizumab 4sintilimab 3pembrolizumab 3Ultrasonography 3Thalidomide 3Leucovorin 3Irinotecan 3Cisplatin 3tislelizumab 2durvalumab 2camrelizumab 2anlotinib 2Walking Speed 2Standard of Care 2Radiosurgery 2Oncolytic Virotherapy 2Metformin 2Liver Transplantation 2Laparoscopy 2Immunohistochemistry 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Liver Neoplasms × Filgrastim × Clear all
NCT00003296 2013-12-19

Liposomal Doxorubicin in Treating Patients With Liver or Bile Duct Cancer

National Cancer Institute (NCI)

Phase 2 Unknown
26 enrolled
Gastrointestinal

Bile Duct Neoplasms, Gallbladder Neoplasms, Carcinoma, Hepatocellular, Liver Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡